Abstract
Use of Convalescent Plasma Therapy for COVID-19: A Scientometric Assessment of Global Publications during 2020-21
Highlights
Since December 2019, a pneumonia outbreak associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had caused a worldwide epidemic
The purpose of this study is to analyze and evaluate the literature on “Use of Convalescent Plasma Therapy for COVID-19” on bibliometric indicators as a way to understand the status of global research in the subject
The search on theme “Use of Convalescent Plasma Therapy for COVID-19” in Scopus database resulted in a total of 820 (2020=790; 2021=30) publications
Summary
Since December 2019, a pneumonia outbreak associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had caused a worldwide epidemic. World Health Organization (WHO) named this virus as coronavirus disease 2019 (COVID-19). It spread rapidly worldwide with a high rate of transmission and substantial mortality. COVID-19 symptoms range from mild, self-limited respiratory disease to severe progressive pneumonia, multiple organ failure, and even death. WHO declared it as a pandemic on March 11, 2020. As of February 2021, a total 103,631,793 confirmed cases and 2251613 deaths had been reported in 223 countries.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
